SciBase Holding AB (publ) (SCIB.ST) stock: key figures, P/E, revenue and dividend

Health Care · Sweden · ISIN SE0007045414

Price
10.65 SEK
Market cap
52.93 m SEK
P/E (2025)
–
P/S (2025)
1.32
Dividend yield
0.00 %
Net margin
-217.50 %
Return on equity (ROE)
-1,307.09 %
Return on assets (ROA)
-166.77 %

SciBase Holding AB (publ) financials

Fiscal year20242025
Revenue29.00 m SEK40.00 m SEK
Gross profit21.00 m SEK27.00 m SEK
EBIT-67.00 m SEK-86.00 m SEK
Net income-61.00 m SEK-87.00 m SEK
Diluted EPS – continuing operations-27.84 SEK-17.52 SEK

Full history since 2012, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About SciBase Holding AB (publ)

SciBase Holding AB (publ), a medical technology company, develops and commercializes point-of-care platforms for skin health management in Europe, the United States, North America, Asia, Oceania, and internationally. It operates through Skin Cancer and Skin Barrier Assessment segments. The company offers Nevisense and Nevisense Go point-of-care platforms to detect melanoma and non-melanoma skin cancer; and for research within skin barrier assessment. It has a collaboration with Mayo Clinic on pigmented lesion digital workflows with AI-driven Nevisense.SciBase Holding AB (publ) was founded in 1998 and is headquartered in Sundbyberg, Sweden.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.